vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -14.9%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-1.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 28.0%).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
IQST vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $75.5M |
| Net Profit | $-2.7M | — |
| Gross Margin | 3.5% | 69.3% |
| Operating Margin | -2.9% | 22.7% |
| Net Margin | -3.2% | — |
| Revenue YoY | -14.9% | 27.7% |
| Net Profit YoY | -44.5% | — |
| EPS (diluted) | $-0.92 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $84.2M | $75.5M | ||
| Q3 25 | $102.9M | $54.5M | ||
| Q2 25 | $72.2M | $52.4M | ||
| Q1 25 | $57.6M | $46.0M | ||
| Q4 24 | $98.9M | $59.1M | ||
| Q3 24 | $54.2M | $80.5M | ||
| Q2 24 | $78.6M | $47.1M | ||
| Q1 24 | $51.4M | $43.8M |
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.3M | $8.8M | ||
| Q2 25 | $-2.3M | $5.9M | ||
| Q1 25 | $-1.1M | $3.0M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-773.0K | $20.3M | ||
| Q2 24 | $-2.0M | $-4.5M | ||
| Q1 24 | $-580.2K | $-4.8M |
| Q4 25 | 3.5% | 69.3% | ||
| Q3 25 | 2.7% | 77.7% | ||
| Q2 25 | 2.6% | 76.5% | ||
| Q1 25 | 3.4% | 77.1% | ||
| Q4 24 | 2.7% | 76.4% | ||
| Q3 24 | 3.7% | 63.9% | ||
| Q2 24 | 2.8% | 77.4% | ||
| Q1 24 | 2.7% | 75.5% |
| Q4 25 | -2.9% | 22.7% | ||
| Q3 25 | -0.5% | 17.6% | ||
| Q2 25 | -0.9% | 12.7% | ||
| Q1 25 | -1.0% | 8.7% | ||
| Q4 24 | -0.3% | 22.6% | ||
| Q3 24 | -0.1% | 27.4% | ||
| Q2 24 | -0.4% | -4.6% | ||
| Q1 24 | -0.4% | -5.3% |
| Q4 25 | -3.2% | — | ||
| Q3 25 | -2.3% | 16.2% | ||
| Q2 25 | -3.3% | 11.2% | ||
| Q1 25 | -2.0% | 6.5% | ||
| Q4 24 | -1.9% | — | ||
| Q3 24 | -1.4% | 25.2% | ||
| Q2 24 | -2.5% | -9.6% | ||
| Q1 24 | -1.1% | -11.0% |
| Q4 25 | $-0.92 | $0.26 | ||
| Q3 25 | $-0.68 | $0.17 | ||
| Q2 25 | $-0.82 | $0.12 | ||
| Q1 25 | $-0.44 | $0.06 | ||
| Q4 24 | $-1.19 | $0.40 | ||
| Q3 24 | $-0.40 | $0.41 | ||
| Q2 24 | $-0.90 | $-0.09 | ||
| Q1 24 | $-0.37 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $97.5M |
| Total DebtLower is stronger | $4.1M | $22.7M |
| Stockholders' EquityBook value | $16.3M | $130.3M |
| Total Assets | $51.1M | $216.3M |
| Debt / EquityLower = less leverage | 0.25× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2M | $97.5M | ||
| Q3 25 | $2.3M | $94.4M | ||
| Q2 25 | $2.0M | $96.0M | ||
| Q1 25 | $1.1M | $93.2M | ||
| Q4 24 | $2.5M | $101.0M | ||
| Q3 24 | $2.1M | $96.7M | ||
| Q2 24 | $797.2K | $96.8M | ||
| Q1 24 | $2.7M | $107.2M |
| Q4 25 | $4.1M | $22.7M | ||
| Q3 25 | $2.7M | $34.0M | ||
| Q2 25 | $4.5M | $45.3M | ||
| Q1 25 | $3.5M | $56.7M | ||
| Q4 24 | $2.5M | $68.0M | ||
| Q3 24 | $3.2M | $79.3M | ||
| Q2 24 | $2.5M | $90.7M | ||
| Q1 24 | $194.0K | $102.0M |
| Q4 25 | $16.3M | $130.3M | ||
| Q3 25 | $17.9M | $115.3M | ||
| Q2 25 | $14.3M | $104.7M | ||
| Q1 25 | $11.6M | $97.1M | ||
| Q4 24 | $11.9M | $92.1M | ||
| Q3 24 | $8.1M | $71.1M | ||
| Q2 24 | $7.6M | $48.5M | ||
| Q1 24 | $8.4M | $51.0M |
| Q4 25 | $51.1M | $216.3M | ||
| Q3 25 | $46.9M | $202.9M | ||
| Q2 25 | $51.4M | $194.9M | ||
| Q1 25 | $42.0M | $196.2M | ||
| Q4 24 | $79.0M | $213.3M | ||
| Q3 24 | $32.4M | $220.7M | ||
| Q2 24 | $30.0M | $205.0M | ||
| Q1 24 | $22.1M | $214.1M |
| Q4 25 | 0.25× | 0.17× | ||
| Q3 25 | 0.15× | 0.30× | ||
| Q2 25 | 0.31× | 0.43× | ||
| Q1 25 | 0.31× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.40× | 1.12× | ||
| Q2 24 | 0.34× | 1.87× | ||
| Q1 24 | 0.02× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $14.4M |
| Free Cash FlowOCF − Capex | $-1.2M | $14.4M |
| FCF MarginFCF / Revenue | -1.5% | 19.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.2M | $14.4M | ||
| Q3 25 | $-953.0K | $9.7M | ||
| Q2 25 | $257.7K | $14.1M | ||
| Q1 25 | $-1.9M | $3.6M | ||
| Q4 24 | $-403.7K | $15.6M | ||
| Q3 24 | $625.0K | $11.0M | ||
| Q2 24 | $-2.6M | $1.0M | ||
| Q1 24 | $-536.9K | $11.2M |
| Q4 25 | $-1.2M | $14.4M | ||
| Q3 25 | $-969.2K | $9.7M | ||
| Q2 25 | $211.7K | $14.1M | ||
| Q1 25 | $-2.0M | $3.6M | ||
| Q4 24 | $-421.3K | $15.6M | ||
| Q3 24 | $594.5K | $11.0M | ||
| Q2 24 | $-2.6M | $1.0M | ||
| Q1 24 | $-608.5K | — |
| Q4 25 | -1.5% | 19.1% | ||
| Q3 25 | -0.9% | 17.7% | ||
| Q2 25 | 0.3% | 26.8% | ||
| Q1 25 | -3.4% | 7.7% | ||
| Q4 24 | -0.4% | 26.4% | ||
| Q3 24 | 1.1% | 13.7% | ||
| Q2 24 | -3.4% | 2.1% | ||
| Q1 24 | -1.2% | — |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
PBYI
Segment breakdown not available.
